Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 30

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 30
---
 ​ | ​ | ​                      | ​ | 5,230 | ​ | ​ |
| Gary Pace(b)         | ​ | ​ | ​                            | ​ | 59,622 | ​ | ​ | ​ | ​                              | ​ |      ― | ​ | ​ | ​ | ​                      | ​ |     ― | ​ | ​ |
| Andreas Wicki(a)​    | ​ | ​ | ​                            | ​ |      ― | ​ | ​ | ​ | ​                              | ​ |      ― | ​ | ​ | ​ | ​                      | ​ |     ― | ​ | ​ |
| Michael Yang         | ​ | ​ | ​                            | ​ | 12,047 | ​ | ​ | ​ | ​                              | ​ | 31,139 | ​ | ​ | ​ | ​                      | ​ | 5,230 | ​ | ​ |
| Alethia Young        | ​ | ​ | ​                            | ​ | 12,047 | ​ | ​ | ​ | ​                              | ​ | 31,139 | ​ | ​ | ​ | ​                      | ​ | 5,230 | ​ | ​ |

(a) Effective January 28, 2025, Paul Hastings and Andreas Wicki resigned from our board. (b) Effective June 30, 2024, Gary Pace retired from our board.

Pacira BioSciences, Inc. 2025 Proxy Statement | 39

TABLE OF CONTENTS Corporate Governance and Board Matters

Stock Ownership Guidelines The People & Compensation Committee believes that requiring named executive officers and members of the board to maintain a minimum level of stock ownership is aligned with stockholder interests and demonstrates a commitment to the Company. As such, in December 2024, the People & Compensation Committee approved the adoption of stock ownership guidelines for the chief executive officer and other named executive officers and increased the stock ownership requirements for members of the board. Under the amended Stock Ownership Guidelines, the chief executive officer is required to own shares of the Company’s common stock equal to at least six times his annual base salary, other named executive officers are required to own shares of the Company’s common stock equal to at least three times their annual base salary, and non-employee directors are required to own shares of the Company’s common stock equal to at least five times the annual cash retainer, which represents an increase from the prior requirement of three times the annual cash retainer. The chief executive officer and other named executive officers have five years to comply and non-employee directors